Commit Biologics Holding ApS: Financial statements 2023
CVR: 42604232
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Commit Biologics Holding ApS (CVR 42604232) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -11,563 and a net result of DKK -13,199. Equity in the 2023 report amounted to DKK 9,742. The solvency ratio was 16.2%.
- Gross Profit
- DKK -11,563
- Profit/Loss
- DKK -13,199
- Equity
- DKK 9,742
- Total Assets
- DKK 60,281
- Employees
- 0
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Commit Biologics Holding ApS has published its interim report for the period August 16, 2021 – December 31, 2022.
About Commit Biologics Holding ApS
Commit Biologics Holding ApS is a Danish company of the type Anpartsselskab based in Auning, founded in 2021. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Nick Stub Laursen, Dennis Vestergaard Pedersen and Heidi Gytz Olesen. The company's owners include Nick Stub Laursen, Dennis Vestergaard Pedersen and Heidi Gytz Olesen. In 2025, the company reported a gross profit of DKK -10,093 and a net result of DKK -12,988 compared with DKK -14,948 the year before. Equity in the 2025 report amounted to DKK -18,193.